| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |